For patients with asthma, an inhaler or inhaler can be a helper first when they experience shortness of breath. However, men who use these drugs regularly big chance of prostate cancer.
The team of scientists in Melbourne, Australia found that men with asthma who use inhalers to potentially enhance tumor growth by 40 percent compared with men who do not suffer from asthma. While users of other types of inhalers, such as bronchodilator, 36 percent higher risk of this disease.
Research that has been published in the journal Cancer Epidemiology, Biomarkers and Prevention, the medical history is based on an analysis of the 1179 people who have been diagnosed with prostate cancer and who have a history of asthma. Initially, they were investigating possible links between asthma and prostate cancer, because both involve inflammation in the body. The survey results revealed, only to have asthma, men have a risk of esophageal tumors up to 25 percent. This risk could be higher if they were users of inhalers. Even according to the research, cancer risk can be increased up to 70 percent in patients with severe asthma often require treatment with steroid tablets or injections.
However, cancer experts stressed that these new findings is a preliminary findings of a small study. Need to do larger studies that examine the relationship between asthma, inhalers and prostate cancer, before a change in use of asthma medications may be considered.
"These results are still quite weak and could be a statistical coincidence," said Dr Jodie Moffat, of Cancer Research. The same opinion expressed by an expert on asthma in the UK, Dr. Elaine Vickers. He urged that people with asthma not to stop taking medicine or stop using the inhaler according to which has been recommended by their physician.
"This study shows that there may be a weak correlation between asthma and risk of prostate cancer. But even if this is true, this association is marginal, and there is no reason for men to worry about asthma," said Dr. Elaine, as quoted from the Daily Mail.
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment